Improvement in individual symptoms and total symptom score (TSS) and matching-adjusted indirect comparison (MAIC) analysis to compare TSS as a continuous endpoint in patients with myelofibrosis treated with pelabresib in combination with ruxolitinib versus janus kinase inhibitor monotherapy Meeting Abstract
| Authors: | Mesa, R.; Kremyanskaya, M.; Patriarca, A.; Gupta, V.; Palandri, F.; Devos, T.; Harrison, C.; Rampal, R. K.; Talpaz, M.; Vannucchi, A.; Kuykendall, A.; Kiladjian, J. J.; Verstovsek, S.; Colak, G.; Dey, D.; Mascarenhas, J. |
| Abstract Title: | Improvement in individual symptoms and total symptom score (TSS) and matching-adjusted indirect comparison (MAIC) analysis to compare TSS as a continuous endpoint in patients with myelofibrosis treated with pelabresib in combination with ruxolitinib versus janus kinase inhibitor monotherapy |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 11056 |
| End Page: | 11059 |
| Language: | English |
| ACCESSION: | WOS:000893230304032 |
| DOI: | 10.1182/blood-2022-159389 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
